Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes
Elisabetta Sauta(IRCCS Humanitas Research Hospital), Matteo Giovanni Della Porta(Humanitas University), Carmen Di Grazia(Ospedale Policlinico San Martino), Lionel Adès(Délégation Paris 7), Francesco Passamonti(University of Insubria), Marie Robin(Universität Hamburg), Saverio D’Amico(Humanitas University), Marilena Bicchieri(Istituti di Ricovero e Cura a Carattere Scientifico), Lin-Pierre Zhao(Assistance Publique – Hôpitaux de Paris), Pierre Fenaux(Hôpital Avicenne), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Matteo Zampini(Humanitas University), Erica Travaglino(Policlinico San Matteo Fondazione), Castellani Gastone(Istituto Nazionale di Fisica Nucleare, Sezione di Bologna), Luca Vago(Vita-Salute San Raffaele University), Claudia Sala, Manja Meggendorfer(Université Paris-Sud), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Shahram Kordasti(Guy's Hospital), Matteo Bersanelli(Humanitas University), Niccolò Bolli(Wellcome Sanger Institute), Guillermo Sanz(Instituto de Salud Carlos III), Daniele Mannina(Humanitas University), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Juan Carlos Caballero Berrocal(Complejo Hospitalario de Salamanca), Maria Teresa Voso(University of Rome Tor Vergata), Massimo Bernardi(Vita-Salute San Raffaele University), Olivier Nibourel(Inserm), Marta Ubezio(Humanitas University), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Giulia Rivoli(Ospedale Policlinico San Martino), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giulia Maggioni(Humanitas University), Luca Lanino(Humanitas University), Valeria Santini(University of Florence), Armando Santoro(IRCCS Humanitas Research Hospital), Antonio Russo(Humanitas University), Marta Riva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Lorenza Borin(Azienda Ospedaliera San Gerardo), Esther Natalie Olíva(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Ulrich Germing(Johannes Gutenberg University Mainz), Elena Riva(Humanitas University)
Cited by 4
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k